A multicenter, open-label, phase II study of PGG beta-glucan and pembrolizumab in patients (pts) with advanced melanoma (MEL) following progression on treatment with checkpoint inhibitors (CPI) or ...
Prognostic and predictive potential of omics studies from blood in pancreatic cancer patients treated with concurrent radiotherapy, gemcitabine, and cetuximab. This is an ASCO Meeting Abstract from ...
Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine
Previous studies have documented that selective delivery of protein antigens to cells expressing mannose receptor (MR) can lead to enhanced immune responses. We postulated that agents that influenced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results